MedTrace Logo

Oxygen Toxicity of HBOT in Chronic Brain Injury

NCT00592891 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-01-05

No results posted yet for this study

Summary

Hypothesis: That HBOT can be toxic in the low-pressure range.

Conditions

  • Adult and Pediatric Chronic Cerebral Disorders

Interventions

DRUG

Hyperbaric oxygen therapy

Total body pressurized oxygen

Sponsors & Collaborators

  • Harch Hyperbaric Research Foundation

    collaborator OTHER

  • Paul G. Harch, M.D.

    lead OTHER

Principal Investigators

  • Paul G Harch, M.D. · LSU School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592891 on ClinicalTrials.gov